Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -31.05 Million ILS | 49.71% |
| 2022 | -61.74 Million ILS | 31.08% |
| 2021 | -89.58 Million ILS | -182.17% |
| 2020 | 109.02 Million ILS | 170.75% |
| 2019 | -154.11 Million ILS | -242.91% |
| 2018 | -44.94 Million ILS | -61.12% |
| 2017 | -27.89 Million ILS | 86.95% |
| 2016 | -213.82 Million ILS | -80.5% |
| 2015 | -118.46 Million ILS | 67.78% |
| 2014 | -367.63 Million ILS | -142.5% |
| 2013 | -151.6 Million ILS | -62.05% |
| 2012 | -93.55 Million ILS | -207.12% |
| 2011 | 87.33 Million ILS | -75.11% |
| 2010 | 350.86 Million ILS | 436.29% |
| 2009 | 65.42 Million ILS | 178.79% |
| 2008 | -83.04 Million ILS | -86.37% |
| 2007 | -44.55 Million ILS | -188.54% |
| 2006 | -15.44 Million ILS | 72.97% |
| 2005 | -57.13 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | 1.21 Million ILS | 119.66% |
| 2023 Q4 | -16.73 Million ILS | 0.0% |
| 2023 Q2 | 1.21 Million ILS | 0.0% |
| 2023 Q3 | -16.73 Million ILS | -1480.45% |
| 2023 FY | -31.05 Million ILS | 49.71% |
| 2022 Q2 | -34.93 Million ILS | -3305.23% |
| 2022 Q3 | -21.72 Million ILS | 37.81% |
| 2022 FY | -61.74 Million ILS | 31.08% |
| 2022 Q4 | -6.16 Million ILS | 71.62% |
| 2022 Q1 | 1.09 Million ILS | 103.33% |
| 2021 Q2 | -35.28 Million ILS | -1243.72% |
| 2021 FY | -89.58 Million ILS | -182.17% |
| 2021 Q4 | -32.69 Million ILS | -72.28% |
| 2021 Q3 | -18.97 Million ILS | 46.22% |
| 2021 Q1 | -2.62 Million ILS | -102.28% |
| 2020 Q4 | 115.42 Million ILS | 755.45% |
| 2020 FY | 109.02 Million ILS | 170.75% |
| 2020 Q1 | -2.78 Million ILS | 91.95% |
| 2020 Q2 | 14 Million ILS | 602.33% |
| 2020 Q3 | -17.61 Million ILS | -225.79% |
| 2019 Q4 | -34.62 Million ILS | -24.49% |
| 2019 Q2 | -78.87 Million ILS | -515.91% |
| 2019 FY | -154.11 Million ILS | -242.91% |
| 2019 Q1 | -12.8 Million ILS | -336.06% |
| 2019 Q3 | -27.81 Million ILS | 64.74% |
| 2018 Q3 | 5.33 Million ILS | 118.07% |
| 2018 Q1 | -26.18 Million ILS | -50.37% |
| 2018 FY | -44.94 Million ILS | -61.12% |
| 2018 Q4 | 5.42 Million ILS | 1.69% |
| 2018 Q2 | -29.51 Million ILS | -12.74% |
| 2017 Q4 | -17.41 Million ILS | -247.04% |
| 2017 Q2 | -4.26 Million ILS | 76.4% |
| 2017 Q1 | -18.06 Million ILS | 83.87% |
| 2017 FY | -27.89 Million ILS | 86.95% |
| 2017 Q3 | 11.84 Million ILS | 377.79% |
| 2016 Q2 | -37.02 Million ILS | -63.39% |
| 2016 Q1 | -22.66 Million ILS | 51.63% |
| 2016 Q3 | -42.19 Million ILS | -13.95% |
| 2016 FY | -213.82 Million ILS | -80.5% |
| 2016 Q4 | -111.94 Million ILS | -165.33% |
| 2015 Q3 | -31.94 Million ILS | -168.41% |
| 2015 FY | -118.46 Million ILS | 67.78% |
| 2015 Q2 | -11.9 Million ILS | 57.15% |
| 2015 Q4 | -46.85 Million ILS | -46.68% |
| 2015 Q1 | -27.77 Million ILS | 90.02% |
| 2014 Q2 | 440.09 Million ILS | 1021.02% |
| 2014 Q1 | -47.78 Million ILS | 12.41% |
| 2014 FY | -367.63 Million ILS | -142.5% |
| 2014 Q4 | -278.33 Million ILS | 42.21% |
| 2014 Q3 | -481.61 Million ILS | -209.43% |
| 2013 Q2 | -56.93 Million ILS | -6247.16% |
| 2013 Q3 | -39.22 Million ILS | 31.11% |
| 2013 FY | -151.6 Million ILS | -62.05% |
| 2013 Q4 | -54.55 Million ILS | -39.08% |
| 2013 Q1 | -897 Thousand ILS | 92.72% |
| 2012 Q3 | -33.45 Million ILS | -239.69% |
| 2012 Q4 | -12.32 Million ILS | 63.16% |
| 2012 FY | -93.55 Million ILS | -207.12% |
| 2012 Q1 | -37.92 Million ILS | 0.0% |
| 2012 Q2 | -9.85 Million ILS | 74.02% |
| 2011 FY | 87.33 Million ILS | -75.11% |
| 2010 FY | 350.86 Million ILS | 436.29% |
| 2009 FY | 65.42 Million ILS | 178.79% |
| 2008 FY | -83.04 Million ILS | -86.37% |
| 2007 FY | -44.55 Million ILS | -188.54% |
| 2006 FY | -15.44 Million ILS | 72.97% |
| 2005 FY | -57.13 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Matricelf Ltd | -12.48 Million ILA | -148.687% |